Pomalidomide-C6-COOH
CAS No. 2225940-50-9
Pomalidomide-C6-COOH ( —— )
Catalog No. M28254 CAS No. 2225940-50-9
Pomalidomide-C6-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 61 | Get Quote |
|
5MG | 88 | Get Quote |
|
10MG | 128 | Get Quote |
|
25MG | 230 | Get Quote |
|
50MG | 347 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePomalidomide-C6-COOH
-
NoteResearch use only, not for human use.
-
Brief DescriptionPomalidomide-C6-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
-
DescriptionPomalidomide-C6-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMIF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2225940-50-9
-
Formula Weight401.4
-
Molecular FormulaC20H23N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CCCCCCNc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sanchez-Zamora Y, et al. Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus. FASEB J. 2010 Jul;24(7):2583-90.
molnova catalog
related products
-
Tyramine hydrochlori...
Tyramine hydrochloride is a biogenic trace amine that is generated via the decarboxylation of the amino acid tyrosine?exhibiting neuromodulatory properties as well as cardiovascular and immunological effects.
-
Rutundic acid
Rutundic acid has antitumor activity, exhibits potent tumor cell growth inhibiting property against Hela, A375, HepG2 , NCI-H446, and SPC-A
-
NotoginsenosideFa
Notoginsenosides Fa and R4 show significant neurite outgrowth enhancing activities in human neuroblastoma SK-N-SH cells.